A detailed history of Godsey & Gibb Associates transactions in Haleon PLC stock. As of the latest transaction made, Godsey & Gibb Associates holds 107 shares of HLN stock, worth $1,004. This represents 0.0% of its overall portfolio holdings.

Number of Shares
107
Previous 50 114.0%
Holding current value
$1,004
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$8.32 - $10.7 $474 - $609
57 Added 114.0%
107 $1,000
Q4 2023

Jan 16, 2024

SELL
$7.78 - $8.62 $12,448 - $13,791
-1,600 Reduced 96.97%
50 $0
Q1 2023

Apr 18, 2023

SELL
$7.57 - $8.37 $4,057 - $4,486
-536 Reduced 24.52%
1,650 $13,000
Q4 2022

Jan 18, 2023

BUY
$5.96 - $8.06 $13,028 - $17,619
2,186 New
2,186 $0

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $43.4B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Godsey & Gibb Associates Portfolio

Follow Godsey & Gibb Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Godsey & Gibb Associates, based on Form 13F filings with the SEC.

News

Stay updated on Godsey & Gibb Associates with notifications on news.